GlassScriptPhysician profile
Zenith Arvind Jameria
NPI 1508122185
$16,559.58
in general payments reported to CMS, 2019-2025
17 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,972 · 2020: $4,790 · 2021: $730 · 2022: $994 · 2023: $402 · 2024: $312 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,182.44 | 2019-2025 | S-Icd System Magnet, Cds - Mct/Cem Monitoring, General - Tachy |
| Abbott Laboratories | $3,109.25 | 2019-2025 | Ensite, Ensite Precision, Gallant |
| Medtronic Vascular, INC. | $2,475.80 | 2019-2020 | |
| Philips North America LLC | $497.27 | 2022-2024 | (9520) Igt Devices Undivided |
| Medtronic, INC. | $386.61 | 2021-2023 | Micra |
| Janssen Pharmaceuticals, INC | $231.27 | 2019-2023 | Xarelto |
| Biotronik INC. | $209.17 | 2020-2025 | Amvia Edge, Biomonitor, Acticor 7 Vr-T Dx |
| Novartis Pharmaceuticals Corporation | $162.16 | 2023-2024 | |
| Baxter Healthcare | $77.87 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Cardiva Medical, INC. | $48.83 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.76 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $31.51 | 2021-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $29.03 | 2023-2024 | Verquvo |
| Amgen INC. | $27.84 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.66 | 2025 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.87 | 2023 | Farxiga |
| Scpharmaceuticals INC. | $15.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zenith Jameria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.